Properdin deficiency associated with recurrent otitis media and pneumonia, and identification of male carrier with Klinefelter syndrome

Clinical Immunology

Volumn 131, Issue 3, 2009, Pages 456-462

  Schejbel, Lone ^a   Rosenfeldt, Vibeke ^b   Marquart, Hanne ^a   Valerius, Niels Henrik ^b   Garred, Peter ^a  

^a Rigshospitalet   (Denmark)

^b Mental Health Services CPH   (Denmark)

Author keywords

Alternative complement pathway; ; Deficiency; ; Immunodeficiency; ; Klinefelter syndrome; Meningococcal disease; ; Otitis media; ; PFC; ; Pneumonia; ; Properdin;

Indexed keywords

PROPERDIN;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT CLASSICAL PATHWAY; COMPLEMENT LECTIN PATHWAY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; FRAMESHIFT MUTATION; GENE; GENE SEQUENCE; GENETIC ANALYSIS; HETEROZYGOTE DETECTION; HUMAN; IMMUNE DEFICIENCY; KLINEFELTER SYNDROME; MALE; NUCLEOTIDE SEQUENCE; OTITIS MEDIA; PAKISTAN; PFC GENE; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT INFECTION; RISK FACTOR; STRUCTURED INTERVIEW; X CHROMOSOME LINKED DISORDER;

FEMALE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; KLINEFELTER SYNDROME; MALE; MUTATION; OTITIS MEDIA; PEDIGREE; PNEUMONIA; PROPERDIN; QUESTIONNAIRES; RECURRENCE; RETROSPECTIVE STUDIES;

EID: 67349249087     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2009.02.008     Document Type: Article

References (40)

1. Schwaeble W., Dippold W.G., Schäfer M.K., Pohla H., Jonas D., Luttig B., Weihe E., Huemer H.P., Dierich M.P., and Reid K.B. Properdin, a positive regulator of complement activation, is expressed in human T cell lines and peripheral blood T cells. J. Immunol. 151 (1993) 2521-2528
2. Schwaeble W., Huemer H.P., Möst J., Dierich M.P., Ströbel M., Claus C., Reid K.B., and Ziegler-Heitbrock H.W. Expression of properdin in human monocytes. Eur. J. Biochem. 219 (1994) 759-764
3. Wirthmueller U., Dewald B., Thelen M., Schäfer M.K., Stover C., Whaley K., North J., Eggleton P., Reid K.B., and Schwaeble W.J. Properdin, a positive regulator of complement activation, is released from secondary granules of stimulated peripheral blood neutrophils. J. Immunol. 158 (1997) 4444-4451
4. Späth P.J., Sjöholm A.G., Fredrikson G.N., Misiano G., Scherz R., Schaad U.B., Uhring-Lambert B., Hauptmann G., Westberg J., Uhlén M., Wadelius C., and Truedsson L. Properdin deficiency in a large Swiss family: identification of a stop codon in the properdin gene, and association of meningococcal disease with lack of the IgG2 allotype marker G2m(n). Clin. Exp. Immunol. 118 (1999) 278-284
5. Fijen C.A., Kuijper E.J., te Bulte M.T., Daha M.R., and Dankert J. Assessment of complement deficiency in patients with meningococcal disease in The Netherlands. Clin. Infect. Dis. 28 (1999) 98-105
6. Densen P. Complement deficiencies and meningococcal disease. Clin. Exp. Immunol. 86 Suppl. 1 (1991) 57-62
7. Figueroa J.E., and Densen P. Infectious diseases associated with complement deficiencies. Clin. Microbiol. Rev. 4 (1991) 359-395
8. Bathum L., Hansen H., Teisner B., Koch C., Garred P., Rasmussen K., and Wang P. Association between combined properdin and mannose-binding lectin deficiency and infection with Neisseria meningitidis. Mol. Immunol. 43 (2006) 473-479
9. Fearon D.T., and Austen K.F. Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase. J. Exp. Med. 142 (1975) 856-863
10. Hourcade D.E. The role of properdin in the assembly of the alternative pathway C3 convertases of complement. J. Biol. Chem. 281 (2006) 2128-2132
11. Kimura Y., Miwa T., Zhou L., and Song W.C. Activator-specific requirement of properdin in the initiation and amplification of the alternative pathway complement. Blood 111 (2008) 732-740
12. Spitzer D., Mitchell L.M., Atkinson J.P., and Hourcade D.E. Properdin can initiate complement activation by binding specific target surfaces and providing a platform for de novo convertase assembly. J. Immunol. 179 (2007) 2600-2608
13. Sjöholm A.G., Braconier J.H., and Söderström C. Properdin deficiency in a family with fulminant meningococcal infections. Clin. Exp. Immunol. 50 (1982) 291-297
14. Fijen C.A., van den Bogaard R., Schipper M., Mannens M., Schlesinger M., Nordin F.G., Dankert J., Daha M.R., Sjöholm A.G., Truedsson L., and Kuijper E.J. Properdin deficiency: molecular basis and disease association. Mol. Immunol. 36 (1999) 863-867
15. Truedsson L., Westberg J., Fredrikson G.N., Sjöholm A.G., Kuijper E.J., Fijen C.A., Späth P.J., and Uhlén M. Human properdin deficiency has a heterogeneous genetic background. Immunopharmacology 38 (1997) 203-206
16. Coleman M.P., Murray J.C., Willard H.F., Nolan K.F., Reid K.B., Blake D.J., Lindsay S., Bhattacharya S.S., Wright A., and Davies K.E. Genetic and physical mapping around the properdin P gene. Genomics 11 (1991) 991-996
17. Nolan K.F., Kaluz S., Higgins J.M., Goundis D., and Reid K.B. Characterization of the human properdin gene. Biochem. J. 287 Pt 1 (1992) 291-297
18. Westberg J., Fredrikson G.N., Truedsson L., Sjöholm A.G., and Uhlén M. Sequence-based analysis of properdin deficiency: identification of point mutations in two phenotypic forms of an X-linked immunodeficiency. Genomics 29 (1995) 1-8
19. Goundis D., and Reid K.B. Properdin, the terminal complement components, thrombospondin and the circumsporozoite protein of malaria parasites contain similar sequence motifs. Nature 335 (1988) 82-85
20. Pangburn M.K. Analysis of the natural polymeric forms of human properdin and their functions in complement activation. J. Immunol. 142 (1989) 202-207
21. Smith C.A., Pangburn M.K., Vogel C.W., and Müller-Eberhard H.J. Molecular architecture of human properdin, a positive regulator of the alternative pathway of complement. J. Biol. Chem. 259 (1984) 4582-4588
22. Fredrikson G.N., Gullstrand B., Westberg J., Sjöholm A.G., Uhlén M., and Truedsson L. Expression of properdin in complete and incomplete deficiency: normal in vitro synthesis by monocytes in two cases with properdin deficiency type II due to distinct mutations. J. Clin. Immunol. 18 (1998) 272-282
23. Higgins J.M., Wiedemann H., Timpl R., and Reid K.B. Characterization of mutant forms of recombinant human properdin lacking single thrombospondin type I repeats. Identification of modules important for function. J. Immunol. 155 (1995) 5777-5785
24. Fredrikson G.N., Westberg J., Kuijper E.J., Tijssen C.C., Sjöholm A.G., Uhlén M., and Truedsson L. Molecular characterization of properdin deficiency type III: dysfunction produced by a single point mutation in exon 9 of the structural gene causing a tyrosine to aspartic acid interchange. J. Immunol. 157 (1996) 3666-3671
25. Seelen M.A., Roos A., Wieslander J., Mollnes T.E., Sjöholm A.G., Wurzner R., Loos M., Tedesco F., Sim R.B., Garred P., Alexopoulos E., Turner M.W., and Daha M.R. Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA. J. Immunol. Methods 296 (2005) 187-198
26. Sjöholm A.G., Söderström C., and Nilsson L.A. A second variant of properdin deficiency: the detection of properdin at low concentrations in affected males. Complement 5 (1988) 130-140
27. Hall T.A. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl. Acids Symp. 41 (1999) 95-98
28. Cunliffe N.A., Snowden N., Dunbar E.M., and Haeney M.R. Recurrent meningococcal septicaemia and properdin deficiency. J. Infect. 31 (1995) 67-68
29. Derkx H.H., Kuijper E.J., Fijen C.A., Jak M., Dankert J., and van Deventer S.J. Inherited complement deficiency in children surviving fulminant meningococcal septic shock. Eur. J. Pediatr. 154 (1995) 735-738
30. Genel F., Atlihan F., Gulez N., Sjöholm A.G., Skattum L., and Truedsson L. Properdin deficiency in a boy with fulminant meningococcal septic shock. Acta Paediatr. 95 (2006) 1498-1500
31. Nielsen H.E., and Koch C. Congenital properdin deficiency and meningococcal infection. Clin. Immunol. Immunopathol. 44 (1987) 134-139
32. Schlesinger M., Nave Z., Levy Y., Slater P.E., and Fishelson Z. Prevalence of hereditary properdin, C7 and C8 deficiencies in patients with meningococcal infections. Clin. Exp. Immunol. 81 (1990) 423-427
33. Söderström C., Sjöholm A.G., Svensson R., and Ostenson S. Another Swedish family with complete properdin deficiency: association with fulminant meningococcal disease in one male family member. Scand. J. Infect. Dis. 21 (1989) 259-265
34. Schlesinger M., Mashal U., Levy J., and Fishelson Z. Hereditary properdin deficiency in three families of Tunisian Jews. Acta Paediatr. 82 (1993) 744-747
35. Linton S.M., and Morgan B.P. Properdin deficiency and meningococcal disease-identifying those most at risk. Clin. Exp. Immunol. 118 (1999) 189-191
36. Wiertsema S.P., Herpers B.L., Veenhoven R.H., Salimans M.M., Ruven H.J., Sanders E.A., and Rijkers G.T. Functional polymorphisms in the mannan-binding lectin 2 gene: effect on MBL levels and otitis media. J. Allergy Clin. Immunol. 117 (2006) 1344-1350
37. Koch A., Melbye M., Sørensen P., Homøe P., Madsen H.O., Mølbak K., Hansen C.H., Andersen L.H., Hahn G.W., and Garred P. Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood. JAMA 285 (2001) 1316-1321
38. van den Bogaard R., Fijen C.A., Schipper M.G., de G.L., Kuijper E.J., and Mannens M.M. Molecular characterisation of 10 Dutch properdin type I deficient families: mutation analysis and X-inactivation studies. Eur. J. Hum. Genet. 8 (2000) 513-518
39. Kolble K., Cant A.J., Fay A.C., Whaley K., Schlesinger M., and Reid K.B. Carrier detection in families with properdin deficiency by microsatellite haplotyping. J. Clin. Invest. 91 (1993) 99-102
40. Morris J.K., Alberman E., Scott C., and Jacobs P. Is the prevalence of Klinefelter syndrome increasing?. Eur. J. Hum. Genet. 16 (2008) 163-170